Propanc Biopharma effects 1-for-1000 reverse stock split effective May 1, 2023

Propanc Biopharma, Inc.

Reverse stock split ratio 1-for-1000, effective May 1, 2023.
Common stock assigned new CUSIP number 74346N602.
No fractional shares issued; fractional shares rounded up to nearest whole share.
Outstanding warrants and equity awards adjusted proportionally.
FINRA processing pending for OTC Pink market price adjustment.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Propanc Biopharma, Inc.: Filed a certificate of amendment to effect a one-for-one thousand reverse stock split of common stock (effective 2023-05-01).

Change: charter amendment
Effective: 2023-05-01

Exact text from the filing

On May 1, 2023, Propanc Biopharma, Inc. (the “Company”) filed a certificate of amendment (the “Certificate of Amendment”) to its certificate of incorporation, as amended (the “Certificate of Incorporation”), to effect a one-for-one thousand reverse stock split (the “Reverse Stock Split”) of its outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), effective as of May 1, 2023.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

Propanc Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-015643

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.